| 1 |
OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential
Hein MD, Kollmus H, Marichal-Gallardo P, Puttker S, Benndorf D, Genzel Y, Schughart K, Kupke SY, Reichl U
Applied Microbiology and Biotechnology, 105(1), 129, 2021 |
| 2 |
Cell culture-based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system
Hein MD, Chawla A, Cattaneo M, Kupke SY, Genzel Y, Reichl U
Applied Microbiology and Biotechnology, 105(19), 7251, 2021 |
| 3 |
A detailed model and Monte Carlo simulation for predicting DIP genome length distribution in baculovirus infection of insect cells
Das A, Dutta S, Sen M, Saxena A, Kumar J, Giri L, Murhammer DW, Chakraborty J
Biotechnology and Bioengineering, 118(1), 238, 2021 |
| 4 |
Cell culture-based production of defective interfering particles for influenza antiviral therapy
Wasik MA, Eichwald L, Genzel Y, Reichl U
Applied Microbiology and Biotechnology, 102(3), 1167, 2018 |
| 5 |
Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production
Frensing T, Pflugmacher A, Bachmann M, Peschel B, Reichl U
Applied Microbiology and Biotechnology, 98(21), 8999, 2014 |
